We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
L3Harris
LHX
$51.6B
| $35.5M | 0.19% |
141,643
-92,356
| -39% | -$21.2M |
|
152
Ciena
CIEN
$53.4B
| $35.3M | 0.19% |
434,502
-380,012
| -47% | -$27.3M |
|
|
WBA
153
DELISTED
Walgreens Boots Alliance
WBA
| $35.2M | 0.19% |
3,067,542
+981,946
| +47% | +$10.9M |
|
154
Logitech
LOGI
$14.7B
| $35.1M | 0.19% |
+389,122
| New | +$31.6M |
|
155
Axsome Therapeutics
AXSM
$11.2B
| $34.6M | 0.18% |
331,131
+27,047
| +9% | +$2.86M |
|
156
Pfizer
PFE
$143B
| $34.6M | 0.18% |
1,425,670
+222,325
| +18% | +$5.18M |
|
157
NewAmsterdam Pharma
NAMS
$3.25B
| $34.4M | 0.18% |
1,897,197
-545,200
| -22% | -$9.94M |
|
158
General Motors
GM
$80.4B
| $34.1M | 0.18% |
693,690
+375,138
| +118% | +$17.8M |
|
159
Amdocs
DOX
$5.92B
| $34M | 0.18% |
372,374
+143,929
| +63% | +$12.9M |
|
|
CTRA
160
DELISTED
Coterra Energy
CTRA
| $34M | 0.18% |
+1,338,042
| New | +$33.9M |
|
161
Regency Centers
REG
$14.7B
| $33.8M | 0.18% |
474,974
+57,340
| +14% | +$4.1M |
|
162
Bank of America
BAC
$435B
| $33.5M | 0.18% |
708,889
+149,475
| +27% | +$6.29M |
|
163
Scholar Rock
SRRK
$5.67B
| $33.5M | 0.18% |
944,432
+84,125
| +10% | +$2.64M |
|
164
HP
HPQ
$24.9B
| $33.4M | 0.18% |
+1,367,125
| New | +$34.8M |
|
|
CAI
165
Caris Life Sciences
CAI
$4.43B
| $33.3M | 0.18% |
+1,246,326
| New | +$33.6M |
|
166
Boston Scientific
BSX
$69.5B
| $33M | 0.17% |
307,663
-100,223
| -25% | -$10.1M |
|
167
McDonald's
MCD
$192B
| $32.7M | 0.17% |
112,038
+10,281
| +10% | +$3.17M |
|
168
Arcus Biosciences
RCUS
$3.55B
| $32.6M | 0.17% |
4,000,029
-1,127,275
| -22% | -$9.63M |
|
169
Rhythm Pharmaceuticals
RYTM
$6.81B
| $32.5M | 0.17% |
+514,381
| New | +$31.5M |
|
170
Hudbay
HBM
$10.1B
| $32.5M | 0.17% |
3,063,295
+812,870
| +36% | +$6.77M |
|
171
PACCAR
PCAR
$69.8B
| $32.5M | 0.17% |
341,735
+329,772
| +2,757% | +$30.5M |
|
|
XHR
172
Xenia Hotels & Resorts
XHR
$1.9B
| $32.4M | 0.17% |
2,579,125
+928,555
| +56% | +$10.6M |
|
173
Weyerhaeuser
WY
$18B
| $32.1M | 0.17% |
1,250,110
+1,025,638
| +457% | +$26.8M |
|
174
Exelixis
EXEL
$13.3B
| $31.9M | 0.17% |
724,816
-91,877
| -11% | -$3.67M |
|
175
BJ's Restaurants
BJRI
$1.42B
| $31.7M | 0.17% |
710,854
+300,565
| +73% | +$11.9M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.